FDA Commissioner Scott Gottlieb’s interest in OTC drug regulations galvanizes the industry to endure “chaos” on Capitol Hill, amplified by uncertainty about the direction of Congress with mid-term elections approaching, say Consumer Healthcare Products Association executives.
“Since assuming the role of commissioner, Dr
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?